Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

BACKGROUND: There is paucity of data on the long-term outcome of the combination of fissurectomy and botulinum toxin A injection for the management of chronic anal fissure. OBJECTIVES: The aim of this study is to assess the safety, efficacy, and long-term outcome of the combination of fissurectomy and botulinum toxin A injection. DESIGN: This is a nonrandomized prospective cohort study. SETTINGS: This study was conducted at a district general hospital in the United Kingdom. PATIENTS: The cohort included all patients treated with fissurectomy and botulinum toxin A for chronic anal fissure between September 2008 and March 2012. INTERVENTION: The patients were treated with a combination of fissurectomy and botulinum toxin A injection. MAIN OUTCOME MEASURES: Symptomatic relief, fissure healing, complications, recurrence, and the need for further surgical intervention. RESULTS: One hundred and two patients received fissurectomy and botulinum toxin A injection for chronic anal fissure. At 12-week follow-up, 68 patients had resolution of symptoms and complete healing of chronic anal fissure, 29 patients had improvement of symptoms but incomplete healing and had further topical or botulinum toxin A treatment with subsequent complete healing. Ninety-five patients (93%) reported no postoperative complications. Seven patients reported a degree of incontinence in the immediate postoperative period. All reported normal continence at12-week follow-up. No local complications were observed or reported. At the mean follow-up of 33 months, there was no evidence of recurrence. Twelve-month follow-up was conducted via telephone interview only. LIMITATIONS: This study is nonrandomized and did not examine the dose response of Botulinum Toxin A. CONCLUSIONS: Fissurectomy combined with high-dose botulinum toxin A is a safe, effective, and durable option for the management of chronic anal fissure and a promising alternative to surgical sphincterotomy.

More information Original publication

DOI

10.1097/DCR.0000000000000434

Type

Journal article

Publication Date

2015-10-01T00:00:00+00:00

Volume

58

Pages

967 - 973

Total pages

6

Keywords

Adult, Anal Canal, Botulinum Toxins, Type A, Chronic Disease, Cohort Studies, Disease Management, Dissection, Fecal Incontinence, Female, Fissure in Ano, Humans, Male, Neuromuscular Agents, Postoperative Complications, Prospective Studies, Recurrence, Treatment Outcome, United Kingdom, Wound Healing